Cancer Letters
Volume 238, Issue 2 , Pages 197-201, 18 July 2006

Combining a matrix metalloproteinase inhibitor, a farnesyltransferase inhibitor, and a taxane improves survival in an anaplastic thyroid cancer model

  • Miaorong She

      Affiliations

    • Department of General Internal Medicine, Ambulatory Treatment and Emergency Care, The University of Texas M. D. Anderson Cancer Center, Houston, TX 77030, USA
    • Dr. M. She is a visiting scholar from the Department of Hematology, Guangdong Provincial People's Hospital, Guangzhou, People's Republic of China.
    • ,
  • Sai-Ching Jim Yeung

      Affiliations

    • Department of General Internal Medicine, Ambulatory Treatment and Emergency Care, The University of Texas M. D. Anderson Cancer Center, Houston, TX 77030, USA
    • Department of Endocrine Neoplasia and Hormonal Disorders, The University of Texas M. D. Anderson Cancer Center, Houston, TX 77030, USA
    • Corresponding Author InformationCorresponding author. Address: The University of Texas M. D. Anderson Cancer Center, 1515 Holcombe Blvd., Box 437, Houston, TX 77030, USA. Tel.: +1 713 745 4516.

Received 30 October 2004; accepted 5 July 2005.

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.

PII: S0304-3835(05)00671-3

doi:10.1016/j.canlet.2005.07.012

Cancer Letters
Volume 238, Issue 2 , Pages 197-201, 18 July 2006

Article Tools

* Image Usage & Resolution